SAN DIEGO, April 11 /PRNewswire/ -- Pharmatek Laboratories, Inc. -- a premier pharmaceutical chemistry development organization supporting the pharmaceutical industry -- today announced the appointment of Yvonne Verburgt to the position of senior director, business development. This follows the company’s recent announcement of the opening of its new facility in March 2007. Verburgt has worked in business development and sales for contract research organizations and biotechnology companies for more than twenty-five years.
“Yvonne is an important addition to the business development team at Pharmatek,” said Timothy Scott, president of Pharmatek. “Her extensive experience as a proven sales representative in the pharmaceutical development outsourcing industry positions Yvonne to make significant contributions to Pharmatek as we move towards the next phase of growth for the company. Under her leadership, I am confident that Pharmatek will continue to expand our pharmaceutical chemistry development business.”
Verburgt joins Pharmatek from Patheon, where she held several posts, including director of North American Pharmaceutical Development Services Sales, senior business manager, and business development manager of west coast sales. As director of North American Sales at Patheon, Verburgt managed a sales team responsible for selling Patheon product development services to pharmaceutical and biotechnology companies. Prior to joining Patheon, Verburgt worked in sales and sales management for such companies as Oread, Inc., Becton Dickinson, Behring Diagnostics, and Johnson & Johnson.
“We are extremely pleased to welcome Yvonne to Pharmatek,” said Dr. Jeffrey Bibbs, CEO and CSO of Pharmatek. “Yvonne’s recognized leadership skills, depth of knowledge of drug development, and commitment to providing client-centric service make her perfectly suited to contribute to the future success of Pharmatek.”
About Pharmatek Laboratories, Inc.
Pharmatek Laboratories Inc. is a pharmaceutical chemistry development company providing full-service pharmaceutical chemistry product development for the pharmaceutical industry. Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing, and stability storage and testing.
Statements contained in this media release which are not historical facts may constitute forward-looking statements. All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those projected including sales forecasts and strategic expansion. The trademarks Pharmatek, Pharmatek Laboratories, Inc., Hot Rod Chemistry and Pharmatek Formulation Screening are all property of Pharmatek Laboratories, Inc. Additional information about Pharmatek Laboratories may be obtained at the Web site http://www.pharmatek.com or by calling 858-587-8783.
Company Contact: Elizabeth Hickman, Marketing Manager Pharmatek Laboratories, Inc. (858) 805-6383 ehickman@pharmatek.com Available Topic Experts: For information on the listed experts, click appropriate link. Jeffrey A. Bibbs http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=48157 Timothy M. Scott http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=50335
Pharmatek Laboratories, Inc.
CONTACT: Elizabeth Hickman, Marketing Manager of Pharmatek Laboratories,Inc., +1-858-805-6383, ehickman@pharmatek.com
Web site: http://www.pharmatek.com/
